PGNY Progyny, Inc.
Healthcare$24.88+0.77%ClosedMarket Cap: $1.95B
As of 2026-05-25
Valuation
P/E (TTM)
24.02
PEG
3.12
P/B
4.58
P/S
1.51
EV/EBITDA
17.05
DCF Value
$23.80
FCF Yield
9.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.1%
Operating Margin
7.5%
Net Margin
5.2%
ROE
13.3%
ROA
9.7%
ROIC
13.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $328.5M | 25.3% | $35.4M | $24.2M | $— | — |
| Q4 null | $318.4M | 24.1% | $15.2M | $12.5M | $— | — |
| FY null | $1.29B | 23.6% | $85.3M | $58.5M | $— | — |
| Q3 null | $313.3M | 23.2% | $21.5M | $13.9M | $— | — |
| Q2 null | $332.9M | 23.7% | $24.4M | $17.1M | $— | — |
| Q1 null | $324.0M | 23.4% | $24.2M | $15.1M | $— | — |
| Q4 null | $298.4M | 21.3% | $15.8M | $10.5M | $— | — |
| FY null | $1.17B | 21.7% | $67.5M | $54.3M | $— | — |
| Q3 null | $286.6M | 20.7% | $12.5M | $10.4M | $— | — |
| Q2 null | $304.1M | 22.5% | $20.7M | $16.5M | $— | — |
| Q1 null | $278.1M | 22.4% | $18.5M | $16.9M | $— | — |
| Q4 2023 | $269.9M | 21.1% | $13.8M | $13.5M | $0.13 | — |